Education/CredentialsFellowship: University of Chicago (Clinical Pharmacology and Pharmacogenomics)Fellowship: University of Chicago Medical Center (Division of Hematology/Oncology)Residency: University of Chicago Medical Center (Internal Medicine)MD: Stanford University School of MedicineBA: Stanford University (Human Biology) Board Certifications & LicensesAmerican Board of Internal Medicine (Medical Oncology) (Certification Date: 2016-10-27)American Board of Internal Medicine (Hematology) (Certification Date: 2017-10-31) - (Recertification Date: 2024-02-10) SpecialtiesHematologyInternal MedicineMedical Oncology Contact Information Vontz Center Office 513-558-2115 Email curraney@ucmail.uc.edu Clinical Interests Hematology and OncologyLeukemiaAcute Lymphocytic LeukemiaAcute Myeloid LeukemiaAmyloidosisCastleman DiseaseChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaLymphadenopathyLymphomaM ProteinMacrocytosisMacroglobulinemiaMantle Cell LymphomaMastocytosisMediastinal AdenopathyMonoclonal gammopathyMonoclonal proteinM-SpikeMycosis FugoidesMyelodysplastic SyndromeMyelomaMyeloproliferative DisorderParaproteinemiaPlasma Cell DisorderPolycythemia veraProteinuriaSideroblastic anemiaT-cell lymphoma Peer Reviewed Publications Curran, Emily; Stock, Wendy 2019. Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL. Blood, 133 16, 1715-1719Wang, Amy Y; Weiner, Howard; Green, Margaret; Chang, Hua; Fulton, Noreen; Larson, Richard A; Odenike, Olatoyosi; Artz, Andrew S; Bishop, Michael R; Godley, Lucy A; Thirman, Michael J; Kosuri, Satyajit; Churpek, Jane E; Curran, Emily; Pettit, Kristen; Stock, Wendy; Liu, Hongtao 2018. A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. Journal of hematology & oncology, 11 1, 4Curran, Emily K; Godfrey, James; Kline, Justin 2017. Mechanisms of Immune Tolerance in Leukemia and Lymphoma. Trends in immunology, 38 7, 513-525Salahudeen, Ameen Abdulla; Patel, Manali I; Baas, Paul; Curran, Walter J; Bradley, Jeffrey D; Gandara, David R; Goss, Glenwood D; Mok, Tony S; Ramalingam, Suresh S; Vokes, Everett E; Malik, Shakun M; Wakelee, Heather A 2017. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe. Clinical lung cancer, 18 1, 5-12Stinchcombe, Thomas E; Zhang, Ying; Vokes, Everett E; Schiller, Joan H; Bradley, Jeffrey D; Kelly, Karen; Curran, Walter J; Schild, Steven E; Movsas, Benjamin; Clamon, Gerald; Govindan, Ramaswamy; Blumenschein, George R; Socinski, Mark A; Ready, Neal E; Akerley, Wallace L; Cohen, Harvey J; Pang, Herbert H; Wang, Xiaofei 2017. Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 25, 2885-2892Yap, Kai Lee; Furtado, Larissa V; Kiyotani, Kazuma; Curran, Emily; Stock, Wendy; McNeer, Jennifer L; Kadri, Sabah; Segal, Jeremy P; Nakamura, Yusuke; Le Beau, Michelle M; Gurbuxani, Sandeep; Raca, Gordana 2017. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leukemia & lymphoma, 58 4, 950-958Curran, Emily; Chen, Xiufen; Corrales, Leticia; Kline, Douglas E; Dubensky, Thomas W; Duttagupta, Priyanka; Kortylewski, Marcin; Kline, Justin 2016. STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia. Cell reports, 15 11, 2357-66Curran, Emily; Corrales, Leticia; Kline, Justin 2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia. Frontiers in oncology, 5 , 83Curran, Emily; Stock, Wendy 2015. How I treat acute lymphoblastic leukemia in older adolescents and young adults. Blood, 125 24, 3702-10Curran, Emily; Smith, Sonali M 2014. Phosphoinositide 3-kinase inhibitors in lymphoma. Current opinion in oncology, 26 5, 469-75Jain, Nitin; Curran, Emily; Iyengar, Neil M; Diaz-Flores, Ernesto; Kunnavakkam, Rangesh; Popplewell, Leslie; Kirschbaum, Mark H; Karrison, Theodore; Erba, Harry P; Green, Margaret; Poire, Xavier; Koval, Greg; Shannon, Kevin; Reddy, Poluru L; Joseph, Loren; Atallah, Ehab L; Dy, Philip; Thomas, Sachdev P; Smith, Scott E; Doyle, L Austin; Stadler, Walter M; Larson, Richard A; Stock, Wendy; Odenike, Olatoyosi 2014. Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 20 2, 490-8Curran, Emily K; Le, Gem M; Sainani, Kristin L; Propp, Jennifer M; Fisher, Paul Graham 2009. Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. Journal of neuro-oncology, 95 1, 81-85Curran, Emily K; Sainani, Kristin L; Le, Gem M; Propp, Jennifer M; Fisher, Paul G 2009. Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry. Pediatric blood & cancer, 52 1, 60-4Partap, Sonia; Curran, Emily K; Propp, Jennifer M; Le, Gem M; Sainani, Kristin L; Fisher, Paul Graham 2009. Medulloblastoma incidence has not changed over time: a CBTRUS study. Journal of pediatric hematology/oncology, 31 12, 970-1Lynch, Thomas J; Bogart, Jeffrey A; Curran, Walter J; DeCamp, Malcolm M; Gandara, David R; Goss, Glenwood; Henschke, Claudia I; Jett, James R; Johnson, Bruce E; Kelly, Karen L; Le Chevalier, Thierry; Mulshine, James L; Scagliotti, Giorgio V; Schiller, Joan H; Shaw, Alice; Thatcher, Nick; Vokes, Everett E; Wood, Douglas E; Hart, Carol 2005. Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. Clinical cancer research : an official journal of the American Association for Cancer Research, 11 13 Pt 2, 4981s-4983sMuffly L.;Curran E. 12-06-2019. Pediatric-inspired protocols in adult acute lymphoblastic leukemia: Are the results bearing fruit? Hematology (United States), 2019 1, 17-23Derman B.A.;Streck M.;Wynne J.;Christ T.N.;Curran E.;Stock W.;Knoebel R.W. 02-23-2020. Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphi Leukemia and Lymphoma, 61 3, 614-622Lyu J.;Curran E.;Ji Y. 01-01-2018. Bayesian adaptive design for finding the maximum tolerated sequence of doses in multicycle dose-find JCO Precision Oncology, 2 , Curran E.;Corrales L.;Kline J. 01-01-2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia Frontiers in Oncology, 5 APR,
Clinical Interests Hematology and OncologyLeukemiaAcute Lymphocytic LeukemiaAcute Myeloid LeukemiaAmyloidosisCastleman DiseaseChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaLymphadenopathyLymphomaM ProteinMacrocytosisMacroglobulinemiaMantle Cell LymphomaMastocytosisMediastinal AdenopathyMonoclonal gammopathyMonoclonal proteinM-SpikeMycosis FugoidesMyelodysplastic SyndromeMyelomaMyeloproliferative DisorderParaproteinemiaPlasma Cell DisorderPolycythemia veraProteinuriaSideroblastic anemiaT-cell lymphoma
Peer Reviewed Publications Curran, Emily; Stock, Wendy 2019. Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL. Blood, 133 16, 1715-1719Wang, Amy Y; Weiner, Howard; Green, Margaret; Chang, Hua; Fulton, Noreen; Larson, Richard A; Odenike, Olatoyosi; Artz, Andrew S; Bishop, Michael R; Godley, Lucy A; Thirman, Michael J; Kosuri, Satyajit; Churpek, Jane E; Curran, Emily; Pettit, Kristen; Stock, Wendy; Liu, Hongtao 2018. A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. Journal of hematology & oncology, 11 1, 4Curran, Emily K; Godfrey, James; Kline, Justin 2017. Mechanisms of Immune Tolerance in Leukemia and Lymphoma. Trends in immunology, 38 7, 513-525Salahudeen, Ameen Abdulla; Patel, Manali I; Baas, Paul; Curran, Walter J; Bradley, Jeffrey D; Gandara, David R; Goss, Glenwood D; Mok, Tony S; Ramalingam, Suresh S; Vokes, Everett E; Malik, Shakun M; Wakelee, Heather A 2017. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe. Clinical lung cancer, 18 1, 5-12Stinchcombe, Thomas E; Zhang, Ying; Vokes, Everett E; Schiller, Joan H; Bradley, Jeffrey D; Kelly, Karen; Curran, Walter J; Schild, Steven E; Movsas, Benjamin; Clamon, Gerald; Govindan, Ramaswamy; Blumenschein, George R; Socinski, Mark A; Ready, Neal E; Akerley, Wallace L; Cohen, Harvey J; Pang, Herbert H; Wang, Xiaofei 2017. Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 25, 2885-2892Yap, Kai Lee; Furtado, Larissa V; Kiyotani, Kazuma; Curran, Emily; Stock, Wendy; McNeer, Jennifer L; Kadri, Sabah; Segal, Jeremy P; Nakamura, Yusuke; Le Beau, Michelle M; Gurbuxani, Sandeep; Raca, Gordana 2017. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leukemia & lymphoma, 58 4, 950-958Curran, Emily; Chen, Xiufen; Corrales, Leticia; Kline, Douglas E; Dubensky, Thomas W; Duttagupta, Priyanka; Kortylewski, Marcin; Kline, Justin 2016. STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia. Cell reports, 15 11, 2357-66Curran, Emily; Corrales, Leticia; Kline, Justin 2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia. Frontiers in oncology, 5 , 83Curran, Emily; Stock, Wendy 2015. How I treat acute lymphoblastic leukemia in older adolescents and young adults. Blood, 125 24, 3702-10Curran, Emily; Smith, Sonali M 2014. Phosphoinositide 3-kinase inhibitors in lymphoma. Current opinion in oncology, 26 5, 469-75Jain, Nitin; Curran, Emily; Iyengar, Neil M; Diaz-Flores, Ernesto; Kunnavakkam, Rangesh; Popplewell, Leslie; Kirschbaum, Mark H; Karrison, Theodore; Erba, Harry P; Green, Margaret; Poire, Xavier; Koval, Greg; Shannon, Kevin; Reddy, Poluru L; Joseph, Loren; Atallah, Ehab L; Dy, Philip; Thomas, Sachdev P; Smith, Scott E; Doyle, L Austin; Stadler, Walter M; Larson, Richard A; Stock, Wendy; Odenike, Olatoyosi 2014. Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 20 2, 490-8Curran, Emily K; Le, Gem M; Sainani, Kristin L; Propp, Jennifer M; Fisher, Paul Graham 2009. Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. Journal of neuro-oncology, 95 1, 81-85Curran, Emily K; Sainani, Kristin L; Le, Gem M; Propp, Jennifer M; Fisher, Paul G 2009. Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry. Pediatric blood & cancer, 52 1, 60-4Partap, Sonia; Curran, Emily K; Propp, Jennifer M; Le, Gem M; Sainani, Kristin L; Fisher, Paul Graham 2009. Medulloblastoma incidence has not changed over time: a CBTRUS study. Journal of pediatric hematology/oncology, 31 12, 970-1Lynch, Thomas J; Bogart, Jeffrey A; Curran, Walter J; DeCamp, Malcolm M; Gandara, David R; Goss, Glenwood; Henschke, Claudia I; Jett, James R; Johnson, Bruce E; Kelly, Karen L; Le Chevalier, Thierry; Mulshine, James L; Scagliotti, Giorgio V; Schiller, Joan H; Shaw, Alice; Thatcher, Nick; Vokes, Everett E; Wood, Douglas E; Hart, Carol 2005. Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. Clinical cancer research : an official journal of the American Association for Cancer Research, 11 13 Pt 2, 4981s-4983sMuffly L.;Curran E. 12-06-2019. Pediatric-inspired protocols in adult acute lymphoblastic leukemia: Are the results bearing fruit? Hematology (United States), 2019 1, 17-23Derman B.A.;Streck M.;Wynne J.;Christ T.N.;Curran E.;Stock W.;Knoebel R.W. 02-23-2020. Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphi Leukemia and Lymphoma, 61 3, 614-622Lyu J.;Curran E.;Ji Y. 01-01-2018. Bayesian adaptive design for finding the maximum tolerated sequence of doses in multicycle dose-find JCO Precision Oncology, 2 , Curran E.;Corrales L.;Kline J. 01-01-2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia Frontiers in Oncology, 5 APR,
Curran, Emily; Stock, Wendy 2019. Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL. Blood, 133 16, 1715-1719Wang, Amy Y; Weiner, Howard; Green, Margaret; Chang, Hua; Fulton, Noreen; Larson, Richard A; Odenike, Olatoyosi; Artz, Andrew S; Bishop, Michael R; Godley, Lucy A; Thirman, Michael J; Kosuri, Satyajit; Churpek, Jane E; Curran, Emily; Pettit, Kristen; Stock, Wendy; Liu, Hongtao 2018. A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. Journal of hematology & oncology, 11 1, 4Curran, Emily K; Godfrey, James; Kline, Justin 2017. Mechanisms of Immune Tolerance in Leukemia and Lymphoma. Trends in immunology, 38 7, 513-525Salahudeen, Ameen Abdulla; Patel, Manali I; Baas, Paul; Curran, Walter J; Bradley, Jeffrey D; Gandara, David R; Goss, Glenwood D; Mok, Tony S; Ramalingam, Suresh S; Vokes, Everett E; Malik, Shakun M; Wakelee, Heather A 2017. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe. Clinical lung cancer, 18 1, 5-12Stinchcombe, Thomas E; Zhang, Ying; Vokes, Everett E; Schiller, Joan H; Bradley, Jeffrey D; Kelly, Karen; Curran, Walter J; Schild, Steven E; Movsas, Benjamin; Clamon, Gerald; Govindan, Ramaswamy; Blumenschein, George R; Socinski, Mark A; Ready, Neal E; Akerley, Wallace L; Cohen, Harvey J; Pang, Herbert H; Wang, Xiaofei 2017. Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 25, 2885-2892Yap, Kai Lee; Furtado, Larissa V; Kiyotani, Kazuma; Curran, Emily; Stock, Wendy; McNeer, Jennifer L; Kadri, Sabah; Segal, Jeremy P; Nakamura, Yusuke; Le Beau, Michelle M; Gurbuxani, Sandeep; Raca, Gordana 2017. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leukemia & lymphoma, 58 4, 950-958Curran, Emily; Chen, Xiufen; Corrales, Leticia; Kline, Douglas E; Dubensky, Thomas W; Duttagupta, Priyanka; Kortylewski, Marcin; Kline, Justin 2016. STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia. Cell reports, 15 11, 2357-66Curran, Emily; Corrales, Leticia; Kline, Justin 2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia. Frontiers in oncology, 5 , 83Curran, Emily; Stock, Wendy 2015. How I treat acute lymphoblastic leukemia in older adolescents and young adults. Blood, 125 24, 3702-10Curran, Emily; Smith, Sonali M 2014. Phosphoinositide 3-kinase inhibitors in lymphoma. Current opinion in oncology, 26 5, 469-75Jain, Nitin; Curran, Emily; Iyengar, Neil M; Diaz-Flores, Ernesto; Kunnavakkam, Rangesh; Popplewell, Leslie; Kirschbaum, Mark H; Karrison, Theodore; Erba, Harry P; Green, Margaret; Poire, Xavier; Koval, Greg; Shannon, Kevin; Reddy, Poluru L; Joseph, Loren; Atallah, Ehab L; Dy, Philip; Thomas, Sachdev P; Smith, Scott E; Doyle, L Austin; Stadler, Walter M; Larson, Richard A; Stock, Wendy; Odenike, Olatoyosi 2014. Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 20 2, 490-8Curran, Emily K; Le, Gem M; Sainani, Kristin L; Propp, Jennifer M; Fisher, Paul Graham 2009. Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. Journal of neuro-oncology, 95 1, 81-85Curran, Emily K; Sainani, Kristin L; Le, Gem M; Propp, Jennifer M; Fisher, Paul G 2009. Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry. Pediatric blood & cancer, 52 1, 60-4Partap, Sonia; Curran, Emily K; Propp, Jennifer M; Le, Gem M; Sainani, Kristin L; Fisher, Paul Graham 2009. Medulloblastoma incidence has not changed over time: a CBTRUS study. Journal of pediatric hematology/oncology, 31 12, 970-1Lynch, Thomas J; Bogart, Jeffrey A; Curran, Walter J; DeCamp, Malcolm M; Gandara, David R; Goss, Glenwood; Henschke, Claudia I; Jett, James R; Johnson, Bruce E; Kelly, Karen L; Le Chevalier, Thierry; Mulshine, James L; Scagliotti, Giorgio V; Schiller, Joan H; Shaw, Alice; Thatcher, Nick; Vokes, Everett E; Wood, Douglas E; Hart, Carol 2005. Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. Clinical cancer research : an official journal of the American Association for Cancer Research, 11 13 Pt 2, 4981s-4983sMuffly L.;Curran E. 12-06-2019. Pediatric-inspired protocols in adult acute lymphoblastic leukemia: Are the results bearing fruit? Hematology (United States), 2019 1, 17-23Derman B.A.;Streck M.;Wynne J.;Christ T.N.;Curran E.;Stock W.;Knoebel R.W. 02-23-2020. Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphi Leukemia and Lymphoma, 61 3, 614-622Lyu J.;Curran E.;Ji Y. 01-01-2018. Bayesian adaptive design for finding the maximum tolerated sequence of doses in multicycle dose-find JCO Precision Oncology, 2 , Curran E.;Corrales L.;Kline J. 01-01-2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia Frontiers in Oncology, 5 APR,